Commercializing a breakthrough advance in inflammation science. MORE
Antibe Therapeutics is a publicly traded biotechnology company exploiting groundbreaking advances in inflammation science.
Antibe Therapeutics Announces Close of Amalgamation Transaction to Unify Intellectual Property Ownership
Antibe Therapeutics to Present at 2021 Bloom Burton & Co. Healthcare Investor Conference
Antibe Therapeutics Receives FDA Clearance of IND Application for Otenaproxesul for Osteoarthritis